18. Secondary endpoints (PATH extension study): Long-term outcomes of subcutaneous immunoglobulin IgPro20 in CIDP maintenance treatmentIvo N. van Schaik,Orell Mielke,Vera Bril,Hans-Peter Hartung,Richard A. Lewis,Gen Sobue,John-Philip Lawo,Michaela Praus,Billie L. Durn,David R. Cornblath,Ingemar S. J. MerkiesClinical Neurophysiology(2020)引用 0|浏览29暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要